SAN DIEGO, July 30, 2014 /PRNewswire/ -- Trovagene, Inc. (NASDAQ: TROV), a developer of cell-free molecular diagnostics, announced today that it will report financial results for the second quarter and the six months ended June 30, 2014 on Thursday, August 7, 2014 at 4:00 p.m. Eastern Daylight Time (1:00 p.m. Pacific Daylight Time).
Trovagene's management team will host a conference call on Thursday, August 7, 2014 at 5:00 p.m. Eastern Daylight Time (2:00 p.m. Pacific Daylight Time) to discuss the results and update investors on the company's progress.
A live webcast of the call will be available online at www.trovagene.investorroom.com . To access the conference call, please dial (877) 870-4263 (domestic), (412) 317-0790 (international), or (855) 669-9657 (Canada), conference ID# 10049887. To access the telephone replay of the call, dial (877) 344-7529 (domestic), (412) 317-0088 (international), or (855) 669-9658 (Canada), replay ID# 10049887. The webcast and telephone replay will be archived on the company's website following the call.
About Trovagene, Inc.
Headquartered in San Diego, California, Trovagene is leveraging its proprietary technology for the detection and monitoring of cell-free DNA and RNA in urine. The Company's technology detects and quantitates oncogene mutations in cancer patients for improved disease management.Trovagene's precision cancer monitoring platform is designed to provide important clinical information beyond the current standardof care, and is protected by significant intellectual property including multiple issued patents and pending patent applications globally.
Contact
Trovagene, Inc. |
David Moskowitz and Amy Caterina |
Investor Relations |
+1 (858) 952-7593 |
ir@trovagene.com |
www.trovagene.com |
Logo - http://photos.prnewswire.com/prnh/20120620/LA28014LOGO
SOURCE Trovagene, Inc.
